COGT Cogent Biosciences, Inc. Common Stock

XNAS 29.52 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

COGT $29.52 —
Key stats
$29.52
52-Week Range
$13.78 – $43.73
YTD
-15.03%
IV Rank (30D)
60.3
Straddle Price
$4.58
P/C Vol Ratio
1.43
Market Cap
$5.1B
Open
$29.47
Day Range
$28.77 – $29.98
Volume
2,783,048
Prev Close
$29.51
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.21%
Beta vs SPY0.78
Cost of Equity (CAPM)9.13% (VRP-adj)
WACC8.94%
Volatility Risk Premium+48.5pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.3B
Return on Equity (TTM)-62.4%
Book / Price11.6%
Debt / Equity0.42
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$34.09 (Market Anchor value)
SMA 20 / Bollinger Mid$30.87
Bollinger Width / SMA2051.8% (drives anchor stability)
Net Debt$0.0B
Market Cap$5B
Peers used for multiples: CORT, CYTK, GH, MIRM, RVMD, SYRE, TVTX, UTHR
60-Day Conviction
60%
20-Day Fair Value
≈ by Nov 16, 2026
$29.39
α -0.4% rank 55%
conviction
27%
40-Day Fair Value
≈ by Dec 15, 2026
$29.94
α +1.4% rank 59%
conviction
45%
60-Day Fair Value
≈ by Jan 13, 2027
$30.00
α +1.6% rank 57%
conviction
60%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0% median 240.3× · 3 peers
Peer P/B $54.59 13% median 15.9× · 5 peers
Peer P/S n/a 0% median 11.8× · 6 peers
Market Anchor (SMA50) $34.09 52% stability 76% (BB-width)
Options Expected (B-L 30d) $29.15 34% 26 strikes · skew +0.66
As of 2026-10-16 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$5.1B
Employees
258
List Date
2018-03-29
CIK
0001622229
Next Earnings
2026-11-06 (After-Close)
EPS Forecast
($0.57) (5 est.)
Headquarters
Waltham, MA
Homepage
https://www.cogentbio.com

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan-28.70%-13.10%36.04%-29.01%19.36%3.37%-2.01%
Feb-13.85%-22.08%-12.85%56.25%-16.24%2.34%-1.07%
Mar6.68%21.99%-17.13%-7.05%-14.43%-1.03%-1.83%
Apr-4.30%-18.94%0.09%-5.80%-10.02%1.56%-6.24%
May-3.02%-33.09%4.63%15.58%-3.37%-4.56%-3.97%
Jun-3.45%111.99%-6.92%0.60%27.99%11.17%23.56%
Jul-25.19%18.10%8.61%5.48%58.17%2.08%11.21%
Aug38.23%59.94%-8.47%14.74%5.96%-9.93%16.75%
Sep-0.24%-12.18%-24.88%-1.37%19.67%-7.67%-4.44%
Oct-0.70%-4.75%-14.55%6.88%15.36%-6.55%*-0.72%
Nov-9.38%-1.87%-6.35%-18.86%159.48%--24.60%
Dec14.25%-8.25%-26.22%-17.63%-10.66%---9.70%
Total-37.72%35.11%-57.77%-3.71%410.63%-10.50%56.01%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $30.77
SMA 50: $33.84
SMA 200: $35.91
Current: $29.52
EMA 12: $29.97
EMA 26: $31.31
MACD: -1.3373 | Signal: -0.0053
BEARISH
ADX (14): 33.30
TREND
+DI: 12.40
−DI: 26.43

Momentum Oscillators

RSI (14): 38.44
NEUTRAL
Stoch %K: 26.37
Stoch %D: 18.55
Williams %R: -64.48

Volume & Volatility

BB Upper: $33.29
BB Lower: $28.25
NEUTRAL
OBV: 87,761,110
Vol SMA 20: 2,336,508
Vol ROC: 136.36%
ATR: $1.39
True Range: $1.21
HV 20: 39.9%
HV 30: 37.9%
HV 60: 46.0%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-18T00:00:00 – 2026-10-16T00:00:00
AI Analysis

LLM Stock Analysis Report

SYMBOL: COGT

Executive Summary Overall Assessment: BEARISH (Confidence Level: 6/10) Key Drivers: * Overbought RSI reading (>70) indicating potential sell signal * High volatility, which can lead to increased market uncertainty and potential price swings Primary Risks: * Technical breakdown below SMA 200 support level ($10.34) * Earnings miss or negative news sentiment that could exacerbate the bearish trend

Recent News Sentiment Impact: No recent news headlines available, which may indicate a lack of catalysts for the stock's movement.

Technical Analysis Trend Direction: * Short-term (1-4 weeks): Bearish * Medium-term (1-3 months): Neutral * Long-term (3-12 months): Bullish

Support/Resistance Levels: * SMA 20: $21.74 * SMA 50: $17.34 * SMA 200: $10.34

Momentum Signals: * RSI interpretation: Overbought (>70), potential sell signal * MACD signal: Bullish, but with a relatively low reading (5.09/1.65) * Bollinger Bands position: Neutral

Volume Analysis: * Volume SMA 20: 4770149.25, indicating a decrease in buying pressure * On-Balance Volume (OBV): 99923528.00, with a declining trend * Volume Rate of Change: -48.75%, suggesting a decrease in volume

News & Sentiment Analysis Recent Headlines Summary: No recent news headlines available.

Sentiment Assessment: Neutral

Catalyst Identification: None identified due to lack of recent news.

Market Narrative: The absence of recent news may indicate a lack of catalysts for the stock's movement, making it more susceptible to market volatility and technical signals.

Risk & Volatility Assessment Beta Interpretation: High risk (beta >1.5), indicating increased volatility relative to the market.

Volatility Regime: Current volatility is higher than historical levels, increasing the risk for investors.

Options Market Signals: * IV rank: 27.9% (Medium), indicating historically average volatility * Put/Call volume ratio: 0.45 (Bullish sentiment) * Put/Call OI ratio: 0.62

Downside Protection: Support levels are available below the current price, but a breakdown below SMA 200 ($10.34) could lead to significant losses.

Market Context & Positioning Sector Performance: Neutral compared to the broader market.

Institutional Activity: Decreasing institutional interest as seen in volume and OBV trends.

Correlation Analysis: COGT's beta is higher than the market, indicating increased volatility relative to the sector.

Relative Valuation: The stock is positioned within a trading range, making it difficult to determine an absolute value.

Key Levels & Action Items Critical Price Levels: * SMA 20 support: $21.74 * SMA 50 support: $17.34

Breakout/Breakdown Levels: * SMA 200 resistance: $10.34 ( potential buy signal)

Time-Sensitive Catalysts: None identified.

Risk Management: Investors should consider setting stop-loss levels below SMA 20 ($21.74) and position sizing considerations to manage risk.

Conclusion

COGT's technical analysis indicates a bearish trend, with an overbought RSI reading suggesting a potential sell signal. The stock's high volatility, coupled with decreasing institutional interest and a lack of recent news, increases the risk for investors. A breakdown below SMA 200 ($10.34) could lead to significant losses, while a breakout above SMA 20 ($21.74) could provide a buying opportunity.

Generated
News
All COGT news →
Earnings History
16 of 16 under expected move
Avg Expected Move
22.38%
Avg Actual Move
3.06%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2022-08-09 After-Close 9.85% 6.31% 0.64x Within
2022-11-14 After-Close 39.98% 3.46% 0.09x Within
2023-05-09 After-Close 12.04% 3.87% 0.32x Within
2023-08-08 After-Close 12.22% 0.34% 0.03x Within
2023-11-02 After-Close 20.79% 0.58% 0.03x Within
2024-02-26 After-Close 24.13% 0.13% 0.01x Within
2024-05-07 After-Close 12.89% 2.06% 0.16x Within
2024-08-06 Pre-Market 33.10% 1.31% 0.04x Within
2024-11-12 After-Close 9.39% 0.19% 0.02x Within
2025-02-25 After-Close 44.71% 4.01% 0.09x Within
2025-05-06 After-Close 44.15% 0.43% 0.01x Within
2025-08-05 Pre-Market 13.07% 5.73% 0.44x Within
2025-11-03 After-Close 48.06% 8.84% 0.18x Within
2026-02-17 After-Close 13.76% 1.94% 0.14x Within
2026-05-05 After-Close 9.73% 3.00% 0.31x Within
2026-08-11 Pre-Market 10.23% 6.81% 0.67x Within

Earnings calendar: this week’s reports with expected vs actual moves →

COGT Options Activity & IV Rank

COGT IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 62.7%
7-DTE IV: —
Expected Move: $4.58
7-DTE Move: $3.02
Days to Exp: 35 (2026-11-20)

Options Flow

Call Volume: 189
Put Volume: 271
P/C Volume: 1.434
BEARISH
Call OI: 3,125
Put OI: 1,053
P/C OI: 0.337
Total OI: 4,178

ATM Options Pricing

ATM Call: $2.08
ATM Put: $2.50
Call %: 7.0%
Put %: 8.5%

Chain Summary

Chain Volume: 4,185
Chain OI: 29,909
Last Updated: 10/16/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
LOW γ vs HISTORY

Estimated net dealer gamma is at the 8th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
8%
vs own history
GEX tilt
-0.25
OI-weighted, today
Vanna tilt
+0.50
δ-sensitivity to IV
Charm tilt
-0.40
δ-decay vs time
Vanna tilt +0.50: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.40: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 22 ATM contracts, 3k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 16 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 16 · ATM 61.8% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)60.3MediumOct 16
Straddle Price (30 DTE)$4.58Oct 16
Beta Analysis

Risk Metrics

Beta: 2.5285
Alpha: 71.78%
Correlation: 0.2519
R-Squared: 6.3%
Stock Volatility: 127.8%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own COGT
6 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$38.6M
0.05%
#424 of 3138+41.0%13F
Millennium Management Hedge fund
Izzy Englander
$37.6M
0.03%
#761 of 3716-8.9%13F
Citadel Hedge fund
Ken Griffin
$32.9M
0.02%
#886 of 6285-50.5%13F
Point72 Hedge fund
Steve Cohen
$28.8M
0.04%
#482 of 1945-47.3%13F
Oaktree Capital Asset manager
Howard Marks
$14.8M
0.28%
#58 of 130+16.3%13F
Rockefeller Capital Management Family office
Rockefeller family
$57K
0.00%
#3301 of 47290.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

COGT Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 155,255,964 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

346 filers431,580,305 shares$8.41B value277.98% of float
# Filer Shares Value % of Total % of Float Period
1 FMR LLC Custodian 27,216,174 $995.76M 11.84% 17.53% 2026-06-30
2 BlackRock, Inc. Custodian 17,352,646 $671.55M 7.99% 11.18% 2026-06-30
3 Vanguard Group Inc Custodian 11,514,326 $408.99M 4.86% 7.42% 2025-12-31
4 Vanguard Portfolio Management LLC 8,072,411 $312.40M 3.72% 5.20% 2026-06-30
5 Vanguard Capital Management LLC 7,412,330 $286.86M 3.41% 4.77% 2026-06-30
6 State Street Corp 6,964,919 $269.54M 3.21% 4.49% 2026-06-30
7 Jupiter Topco LLC 10,546,848 $261.28M 3.11% 6.79% 2026-06-30
8 Janus Henderson Group plc 9,620,125 $234.11M 2.78% 6.20% 2026-03-31
9 Fairmount Funds Management LLC 5,503,418 $212.98M 2.53% 3.54% 2026-06-30
10 DEERFIELD MANAGEMENT COMPANY, L.P. 5,006,104 $193.74M 2.30% 3.22% 2026-06-30
11 TCG Crossover Management, LLC 4,854,436 $187.87M 2.23% 3.13% 2026-06-30
12 T. Rowe Price Associates, Inc. 4,652,727 $180.06M 2.14% 3.00% 2026-06-30
13 Geode Capital Management, LLC Custodian 4,508,998 $174.53M 2.08% 2.90% 2026-06-30
14 Wellington Management Group LLP Custodian 4,343,977 $168.11M 2.00% 2.80% 2026-06-30
15 LORD, ABBETT & CO. LLC 11,583,030 $142.88M 1.70% 7.46% 2026-06-30
16 Kynam Capital Management, LP 3,667,097 $141.92M 1.69% 2.36% 2026-06-30
17 Polar Capital Holdings Plc 3,232,905 $125.11M 1.49% 2.08% 2026-06-30
18 Commodore Capital LP 3,050,000 $118.03M 1.40% 1.96% 2026-06-30
19 Linden Advisors LP 89,165,000 $108.94M 1.30% 57.43% 2026-06-30
20 Invesco Ltd. Custodian 2,609,141 $100.97M 1.20% 1.68% 2026-06-30
21 Woodline Partners LP 2,603,162 $100.74M 1.20% 1.68% 2026-06-30
22 Pictet Asset Management Holding SA 2,393,515 $92.63M 1.10% 1.54% 2026-06-30
23 Octagon Capital Advisors LP 2,350,000 $90.94M 1.08% 1.51% 2026-06-30
24 RTW INVESTMENTS, LP 2,309,021 $89.36M 1.06% 1.49% 2026-06-30
25 Goldman Sachs Group Inc Custodian 2,288,633 $88.57M 1.05% 1.47% 2026-06-30
8 filers$56.09M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $23.12M 41.22% 2026-06-30
2 Caption Management, LLC $7.12M 12.70% 2026-06-30
3 GROUP ONE TRADING LLC Custodian $6.56M 11.70% 2026-06-30
4 Jane Street Group, LLC Custodian $5.78M 10.31% 2026-06-30
5 Citadel Advisors LLC Custodian $5.72M 10.20% 2026-06-30
6 Balyasny Asset Management L.P. $3.87M 6.90% 2026-06-30
7 Simplex Trading, LLC Custodian $2.36M 4.22% 2026-06-30
8 DLD Asset Management, LP $1.55M 2.76% 2026-06-30
7 filers$15.61M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $7.47M 47.88% 2026-06-30
2 Citadel Advisors LLC Custodian $2.91M 18.65% 2026-06-30
3 Caption Management, LLC $1.94M 12.40% 2026-06-30
4 Simplex Trading, LLC Custodian $1.73M 11.06% 2026-06-30
5 Jane Street Group, LLC Custodian $603.72K 3.87% 2026-06-30
6 GROUP ONE TRADING LLC Custodian $541.80K 3.47% 2026-06-30
7 WOLVERINE ASSET MANAGEMENT LLC $417.96K 2.68% 2026-06-30

COGT Insider Trading (Form 4)

Latest: 2026-10-05
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-05 Karen Jean Ferrante Director Grant (A) +759 opt — EDGAR
2026-08-31 Arlene Morris Director Mixed — $21.26 -$1.44M EDGAR
2026-07-06 Karen Jean Ferrante Director Grant (A) +627 opt — EDGAR
2026-06-11 Arlene Morris Director Grant (A) +17,901 opt — EDGAR
2026-06-11 Christopher W. Cain Director Grant (A) +17,901 opt — EDGAR
2026-06-11 Karen Jean Ferrante Director Grant (A) +17,901 opt — EDGAR
2026-06-11 Matthew Ros Director Grant (A) +17,901 opt — EDGAR
2026-06-11 Peter Evan Harwin Director Grant (A) +17,901 opt — EDGAR
2026-06-11 Todd Shegog Director Grant (A) +17,901 opt — EDGAR
2026-05-21 Andrew R Robbins President and CEO Gift (G) — — EDGAR
2026-04-03 Karen Jean Ferrante Director Grant (A) +686 opt — EDGAR
2026-01-22 Fairmount Funds Management LLC Director Sell (S) −3,500,000 $36.40 -$127.40M EDGAR
2026-01-05 Karen Jean Ferrante Director Grant (A) +643 opt — EDGAR
2025-12-30 Jessica Sachs Chief Medical Officer Sell (S) −82,642 $38.70 -$3.20M EDGAR
2025-12-30 Evan Kearns Chief Legal Officer Sell (S) −65,000 $38.70 -$2.52M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

COGT Insider Holdings

8 insiders · @ $29.52
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Fairmount Funds Management LLC Director 5,503,418 $162.46M -$82.90M 7 2026-01-22
2 Andrew R Robbins President and CEO 657,503 $19.41M $0 9 2026-05-21
3 John Edward Robinson Chief Scientific Officer 140,002 $4.13M -$3.49M 6 2025-12-30
4 Jessica Sachs Chief Medical Officer 133,938 $3.95M -$3.20M 10 2025-12-30
5 John L. Green Chief Financial Officer 131,834 $3.89M -$3.14M 11 2025-12-30
6 Evan Kearns Chief Legal Officer 109,398 $3.23M -$2.52M 7 2025-12-30
7 Cole Pinnow Chief Commercial Officer 97,450 $2.88M $332.4K 4 2025-12-19
8 Arlene Morris Director 45,510 $1.34M -$1.69M 7 2026-08-31
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

COGT Proposed Insider Sales (Form 144)

Latest: 2026-08-27
Last 30d: 0 filings  ·  Last 90d: 1 filing · $1.7M notice value · 1 unique filer · 100% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: ARLENE MORRIS (1, $1.7M)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-08-27 ARLENE MORRIS Director 45,510 $1.67M 2026-08-27 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-03-31 Fairmount Healthcare Fund II L.P. Director 7,000,000 $242.62M 2026-03-31 Goldman Sachs & Co. LLC — EDGAR
2026-01-22 Fairmount Healthcare Fund II L.P. Director 3,500,000 $127.40M 2026-01-22 Jefferies LLC — EDGAR
2025-12-29 JESSICA SACHS Officer 82,642 $3.20M 2025-12-26 Morgan Stanley Smith Barney LLC … — EDGAR
2025-12-29 JOHN ROBINSON Officer 90,000 $3.49M 2025-12-26 Morgan Stanley Smith Barney LLC … — EDGAR
2025-12-29 JOHN GREEN Officer 77,000 $2.98M 2025-12-26 Morgan Stanley Smith Barney LLC … — EDGAR
2025-12-29 EVAN D KEARNS Officer 65,000 $2.52M 2025-12-26 Morgan Stanley Smith Barney LLC … — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
71 ETFs hold COGT
25 shown · $892.30M total exposure · 0.16% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.01% $166.0M — 2026-09-30
2 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.17% $127.5M $75.2B 2026-10-15
3 XBI State Street® SPDR® S&P® Biotech ETF SPDR (State Street) 1.18% $121.9M $10.3B 2026-10-15
4 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.07% $118.7M — 2026-09-30
5 VBR Vanguard Morningstar Small-Cap Value ETF Vanguard 0.12% $77.3M — 2026-09-30
6 VXF Vanguard Extended Market ETF Vanguard 0.07% $62.7M — 2026-09-30
7 IWO iShares Russell 2000 Growth ETF iShares (BlackRock) 0.34% $45.9M $13.4B 2026-10-15
8 IBB iShares Biotechnology ETF iShares (BlackRock) 0.33% $35.3M $10.5B 2026-10-15
9 VTWO Vanguard Russell 2000 ETF Vanguard 0.18% $31.0M — 2026-09-30
10 SCHA Schwab U.S. Small-Cap ETF Nport 0.11% $25.8M — 2026-05-31
11 VHT Vanguard Health Care ETF Vanguard 0.06% $13.0M — 2026-09-30
12 FESM Fidelity Enhanced Small Cap Core ETF Fidelity 0.13% $8.6M $6.6B 2026-10-15
13 LFSC F/m Emerald Life Sciences Innovation ETF Nport 7.53% $7.9M — 2026-05-31
14 CANC Tema Oncology ETF Nport 4.10% $7.2M — 2026-05-31
15 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.01% $6.7M $96.0B 2026-10-15
16 VTWG Vanguard Russell 2000 Growth ETF Vanguard 0.35% $5.8M — 2026-09-30
17 LABU Direxion Daily S&P Biotech Bull 3X ETF Direxion 0.86% $5.0M — 2026-10-16
18 VT Vanguard Total World Stock ETF Vanguard 0.00% $4.4M — 2026-09-30
19 FFSM Fidelity Fundamental Small-Mid Cap ETF Nport 0.25% $3.7M — 2026-07-31
20 FSMD Fidelity Small-Mid Multifactor ETF Fidelity 0.13% $3.3M $2.5B 2026-10-15
21 SCHB Schwab U.S. Broad Market ETF Nport 0.01% $3.2M — 2026-05-31
22 TMSL T. Rowe Price Small-Mid Cap ETF Nport 0.12% $3.2M — 2026-06-30
23 USVM VictoryShares US Small Mid Cap Value Momentum ETF Nport 0.17% $2.9M — 2026-06-30
24 DWAS Invesco Dorsey Wright SmallCap Momentum ETF Nport 0.64% $2.7M — 2026-05-31
25 RSSL Global X Russell 2000 ETF Global X 0.17% $2.4M — 2026-10-16
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-2.14
TTM Revenue
—
TTM Net Income
$-332.40M
TTM Op. Cash Flow
$-307.55M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30—$-88.93M$-0.52$-77.27M
Q1 '262026-03-31—$-86.02M$-0.53$-86.88M
Q4 '252025-12-31—$-88.42M$-0.61$-79.11M
Q3 '252025-09-30—$-69.03M$-0.50$-64.29M
Q2 '252025-06-30—$-60.88M$-0.53$-54.54M
Q1 '252025-03-31—$-59.47M$-0.52$-66.51M
Q4 '242024-12-31—$-55.58M$-0.50$-60.58M
Q3 '242024-09-30—$-57.41M$-0.52$-51.98M
Q2 '242024-06-30—$-42.87M$-0.43$-42.70M
Q1 '242024-03-31—$-46.08M$-0.49$-52.53M
Q4 '232023-12-31—$-16.88M$-0.15$-44.07M
Q3 '232023-09-30—$-55.38M$-0.64$-37.97M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-10
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
8.61
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-62.4%
ROA
-39.8%
Div Yield
0.00%
FCF Yield
-6.71%
Debt/Equity
0.42
Current Ratio
—
Market Cap
$4.58B
as of 2026-10-16
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
19.46M
SI % of Float
13.02%
Days to Cover
8.08
Short Vol Ratio
80.6%
Free Float
149.46M
Float %
86.1%
Short interest 2026-09-30 • Short volume 2026-10-16 • Float 2026-08-24